NeoGenomics stock plunges more than 20% as CEO departs after disappointing quarter

NeoGenomics Inc. Chief Executive Mark Mallon stepped down Monday as the health-testing company revealed that first-quarter financials will miss guidance and rescinded its forecast for the full year, s...

The Good And Bad: Hillenbrand & NeoGenomics

Blue double exposure of money coins stacking with bar graph for financial and investment business … [+] concept. getty Recap From December’s Picks The Most Attractive Stocks (+2.2%) underperform...